RE: IV OV+ICI sequential administration in clinical trials Candel is another OV company that injects its HSV vectors directly into the tumor or surrounding tissue.
https://www.biospace.com/article/carl-june-s-upenn-lab-teams-up-with-candel-to-combine-viral-immunotherapy-with-car-t/